VKORC1 polymorphisms in Amerindian populations of Brazil.

Pharmacogenomics

Divisão de Farmacologia, Instituto Nacional de Câncer, Rua André Cavalcanti 37, Rio de Janeiro 20231-050, Brazil.

Published: November 2008

Noncoding polymorphisms in the VKORC1 gene associate with variation of interindividual dosing requirements of warfarin and other coumarin anticoagulants. The frequency of VKORC1 polymorphisms displays distinct interpopulation differences. Here, we report the distribution of the VKORC1 3673G>A, 5808T>G, 6853G>C and 9041G>A SNPs in three endogamous Amerindian (Native American) populations, namely, Guarani-Kaiowá, Guarani-Nandeva and Kaingang. Individual DNA from 180 healthy adults was genotyped for the VKORC1 polymorphisms using TaqMan Detection System assays. The ARLEQUIN 3.1 software package was used to estimate haplotype frequency and linkage disequilibrium. The VKORC1 3673G>A, 5808T>G, 6853G>C and 9041G>A polymorphisms were in Hardy-Weinberg equilibrium in each population. The 5808G allele was absent or rare (<3%), whereas 3673A, 6853C and 9041A were frequent (34-63%) in the three Amerindian populations. No difference was detected in allele or genotype frequency bewteen the two Guarani populations, whereas significant differences were observed between Kaingang and Guarani. Polymorphisms 3673G>A, 6853G>C and 9041G>A were in significant linkage disequilibrium in both Guarani and Kaingang (pairwise r2 values: 0.77-1.0). Haplotypes ATCG and GTGA accounted for more than 94% of the haplotypes in both populations, ATCG being the most common in Guarani (49.5%) and GTGA in Kaingang (54%). These data disclose the uniqueness of the frequency distribution of the VKORC1 SNPs in the Amerindians, compared with Asian, African and European populations. In view of the vast interpopulational diversity among Amerindians, the present data should not be interpreted as representative of other extant Amerindian peoples. Our estimates that 40% of Kaingang and 60% of Guarani have haplotypes including the variant 3673A allele suggest that these two Amerindian populations comprise high proportions of individuals requiring reduced warfarin doses.

Download full-text PDF

Source
http://dx.doi.org/10.2217/14622416.9.11.1623DOI Listing

Publication Analysis

Top Keywords

vkorc1 polymorphisms
12
6853g>c 9041g>a
12
amerindian populations
8
distribution vkorc1
8
vkorc1 3673g>a
8
3673g>a 5808t>g
8
5808t>g 6853g>c
8
linkage disequilibrium
8
vkorc1
7
populations
5

Similar Publications

Inter-individual variability in drug responses is significantly influenced by genetic factors, underscoring the importance of population-specific pharmacogenomic studies to optimize clinical outcomes. In this study, we analyzed whole genome sequencing data from 949 unrelated Thai individuals and conducted an in-depth analysis of 3239 genes involved in drug pharmacokinetics, pharmacodynamics, or immune-mediated adverse drug reactions. We identified 43 single nucleotide polymorphisms (SNPs), 134 diplotypes, and 15 human leukocyte antigen (HLA) alleles, all with moderate to high clinical significance.

View Article and Find Full Text PDF

Vkorc1 polymorphisms of the Norway rats in China: Implications for rodent management and evolutionary origin of anticoagulant resistance mutations.

Sci Total Environ

December 2024

State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, China. Electronic address:

Article Synopsis
  • The rise in use of second-generation anticoagulant rodenticides (SGARs) has sparked concerns about their safety for non-target animals and environmental effects.
  • Research has identified specific mutations in the Vkorc1 gene that lead to anticoagulant resistance in Norway rats, particularly noting three mutations (A26T, C96Y, A140T) found in rat populations across China.
  • Understanding these mutations and their origins can help in developing more effective rodent control strategies, emphasizing the need to adopt less toxic first-generation anticoagulant rodenticides (FGARs) in susceptible areas.
View Article and Find Full Text PDF

A survey of VKORC1 missense mutations in eleven Italian islands reveals widespread rodenticide resistance in house mice.

Sci Total Environ

November 2024

Università degli studi di Roma "La Sapienza", Dipartimento di Biologia e Biotecnologie "Charles Darwin", via Borelli 50, 00188 Rome, Italy; National Biodiversity Future Center, 90133 Palermo, Italy.

To protect native wildlife, more than one hundred rodent eradications have been attempted in the Mediterranean islands by using anticoagulant rodenticides (ARs). Despite their high efficiency, resistance to ARs has been observed in many countries and it is mostly related to missense mutations (SNPs) in the VKORC1 gene. The presence of resistant individuals reduces the efficiency of rodent management, leading to an excessive use of ARs.

View Article and Find Full Text PDF

Meta-analysis of genome-wide association studies of stable warfarin dose in patients of African ancestry.

Blood Adv

October 2024

Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.

Article Synopsis
  • Warfarin dosing is affected by individual clinical and genetic factors, with a need to explore genetic variants specific to African populations for better dosing guidance.
  • A genome-wide association study (GWAS) focused on 989 warfarin-treated participants from Uganda, South Africa, and Zimbabwe, as well as African American cohorts, found significant genetic variants associated with warfarin response.
  • The study highlighted the importance of the CYP2C9 and VKORC1 genes and identified a new potential genetic locus (MALL) that may impact warfarin response, warranting further research to understand its biological relevance.
View Article and Find Full Text PDF

Effect of genetic factors on the interindividual variability of warfarin dosage requirements in Japanese patients after adjusting for renal function.

Pharmazie

August 2024

Laboratory of Clinical Pharmacy, Faculty of Pharmacy, Takasaki University of Health and Welfare; Education Center for Clinical Pharmacy, Faculty of Pharmacy, Takasaki University of Health and Welfare.

Renal function significantly influences the appropriate warfarin dosage. However, studies investigating the impact of genetic factors on warfarin dosage, considering renal function, are limited. This study aimed to assess the role of genetic polymorphisms in , , , , , and in warfarin dosage adjustment considering renal function.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!